Shares Outstanding (Quarterly) Chart

View Shares Outstanding (Quarterly) for RVMD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shares Outstanding (Quarterly) Chart
Start Trial

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 2018. Start Trial.
Date Value
June 30, 2026 214.24M
March 31, 2026 200.18M
December 31, 2025 197.00M
September 30, 2025 189.71M
June 30, 2025 186.90M
March 31, 2025 186.26M
December 31, 2024 185.90M
September 30, 2024 167.75M
June 30, 2024 165.65M
March 31, 2024 164.91M
December 31, 2023 164.67M
September 30, 2023 109.45M
June 30, 2023 109.14M
March 31, 2023 106.30M
December 31, 2022 90.41M
September 30, 2022 87.82M
Date Value
June 30, 2022 74.46M
March 31, 2022 74.23M
December 31, 2021 74.14M
September 30, 2021 73.65M
June 30, 2021 73.58M
March 31, 2021 73.44M
December 31, 2020 66.60M
September 30, 2020 66.32M
June 30, 2020 59.02M
March 31, 2020 59.00M
December 31, 2019 59.00M
September 30, 2019 56.90M
June 30, 2019 56.90M
March 31, 2019 56.90M
December 31, 2018 59.00M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
Tango Therapeutics, Inc. 168.38M
Erasca, Inc. 312.56M
Arrowhead Pharmaceuticals, Inc. 141.14M
Intellia Therapeutics, Inc. 140.02M
Beam Therapeutics, Inc. 103.26M